Kawai T, Washizuka M, Takahashi T, Kusuyama H
Gan To Kagaku Ryoho. 1984 May;11(5):999-1004.
The incidence of prostate cancer has recently increased in Japan. Since Huggins demonstrated the dramatic effect of antiandrogenic treatment, patients with prostate cancer are widely treated by bilateral orchiectomy and high dose estrogen. As the incidence of cardiovascular disease has also gradually increased in patients of prostate cancer treated by estrogen in Japan, radiotherapy, radical prostatectomy, antiandrogen such as chlormadinone acetate, cyproterone acetate and anticancer chemotherapy are now sought and tested clinically. The authors have emphasized multidisciplinary treatment according to the stage of prostate cancer. In particular, early prostate cancer without metastasis should be radically treated with radiotherapy or prostatectomy.
最近日本前列腺癌的发病率有所上升。自从哈金斯证明了抗雄激素治疗的显著效果以来,前列腺癌患者广泛接受双侧睾丸切除术和高剂量雌激素治疗。由于在日本接受雌激素治疗的前列腺癌患者中,心血管疾病的发病率也逐渐上升,目前正在临床寻求并测试放射治疗、根治性前列腺切除术、醋酸氯地孕酮和醋酸环丙孕酮等抗雄激素药物以及抗癌化疗。作者强调应根据前列腺癌的分期进行多学科治疗。特别是,无转移的早期前列腺癌应采用放射治疗或前列腺切除术进行根治性治疗。